Volume : 12, Issue : 11, November – 2025
Title:
CURRENT REGULATIONS FOR HERBAL PRODUCTS
Authors :
Dumpala Yashwanth, V. Lavanya, Dr.l. Harikiran.
Abstract :
Officinal plants and their products have great social and economic consequences, and today they are used in four principal sectors: food, cosmetics, health and medicine. The medicinal use of the herbaI drugs, Phytotherapy, is differently controlled in different countries, but with only marginal differences because phytotherapeutic products must possess quality, safety and efficacy. The use of herbs as health foods, as well as food supplements, complicates the formulation of regulations by countries throughout the world. The increasing supply of herbal products to international markets makes it necessary for international organizations, such as the World Health Organization (WHO) to develop standards relative to their commercialization throughout the world. The classification of drugs varies from country to country, with active foods, dietary supplements and traditional medicines being included in certain categories. The stability of those products is also unknown and complex to the critical problem in the analysis of herbal products that this is a complex ingredient combination, as well as the elements responsible for the treatment effects. In order to identify the changes to the newly introduced regulations or regulations, detailed literary searches and online searches for herbal medicinal products regulations have been made in South-east Asia and European countries.
Cite This Article:
Please cite this article in press Dumpala Yashwanth et al., Current Regulations For Herbal Products, Indo Am. J. P. Sci, 2025; 12(11).
REFERENCES:
1. “Hard to swallow”. Nature. 448 (7150): 105–6. July 2007. Bibcode:2007Natur.448S.105.. doi:10.1038/448106a. PMID 17625521.
2. Jump up to:a b Lack CW, Rousseau J (2016). Critical Thinking, Science, and Pseudoscience: Why We Can’t Trust Our Brains. Springer Publishing Company. pp. 212–214. ISBN 9780826194268.
3. Jump up to:a b “Herbal medicine”. Cancer Research UK. 2 February 2015. Retrieved 12 November 2018.
4. Jump up to:a b c d Tyler VE (31 August 1999). “False Tenets of Paraherbalism”. Quackwatch. Retrieved 29 October 2016.
5. Current Prospects of Herbal Medicines in the World.
6. Brief history of herbalism http://exhibits.hsl.virginia.edu/herbs/briefhistory.
7. “Traditional medicine, Factsheet No. 134”. World Health Organization. May 2003. Archived from the original on 8 June 2003.
8. Moerman DE (1997). “Ethnobotany in North America”. In Selin, Helaine (ed.). Encyclopaedia of the History of Science, Technology, and Medicine in Non-Western Cultures. Springer. p. 321. ISBN 9780792340669.
9. Bussmann RW, Sharon D (November 2006). “Traditional medicinal plant use in Northern Peru: tracking two thousand years of healing culture”. Journal of Ethnobiology and Ethnomedicine. 2 (1): 47. doi:10.1186/1746-4269-2-47. PMC 1637095. PMID 17090303.
10. Yuan D, Yang X, Guo JC (May 2016). “A great honor and a huge challenge for China: You-you TU getting the Nobel Prize in Physiology or Medicine”. Journal of Zhejiang University. Science. B. 17 (5): 405–8. doi:10.1631/jzus.B1600094. PMC 4868832. PMID 27143269.
11. Kala CP (2006). “Preserving Ayurvedic herbal formulations by Vaidyas: The traditional healers of the Uttaranchal Himalaya region in India”. HerbalGram. 70: 42–50.
12. Kala CP (2005). “Health traditions of Buddhist community and role of amchis in trans-Himalayan region of India”. Current Science. 89 (8): 1331–38.
13. Kala CP (2003). Medicinal plants of Indian trans-Himalaya. Dehradun: Bishen Singh Mahendra Pal Singh. p. 200.
14. Petrovska BB (January 2012). “Historical review of medicinal plants’ usage”. Pharmacognosy Reviews. 6 (11): 1–5. doi:10.4103/0973-7847.95849. PMC 3358962. PMID 22654398.
15. Wahono T (21 February 2012). “Jejak Mataram Kuno di Sindoro” [Traces of Ancient Mataram in Sindoro]. KOMPAS (in Indonesian).
16. Jump up to:a b c “Jamu dan Lulur, Rahasia Cantik Para Putri Keraton”. Tribun Jogja (in Indonesian). 21 May 2013. Retrieved 4 November 2015.
17. Society, National Geographic (20 August 2020). “Dividing Species: Wallace Line Map”. National Geographic Society. Retrieved 4 May 2022.
18. Beers SJ (2001). Jamu: The Ancient Indonesian Art of Herbal Healing. Periplus Editions (HK) Limited. ISBN 978-962-593-503-4.
19. https://www.britannica.com/science/phytotherapy
20. De Smet PAGM (1997). The role of plant-derived drugs and herbal medicines in healthcare. Drugs, 54: 801-840.
21. Blumenthal M (1999). Harvard study estimates consumers spend $5.1 billion on herbal products? HerbalGram, 45: 68.
22. Blumenthal M (1999). Herb industry sees mergers, acquisitions, and entry by pharmaceutical giants in 1998. HerbalGram, 45: 67-68.
23. Grünwald J (1995). The European phytomedicines market: figures, trends, analysis. HerbalGram, 34: 60-65.
24. Roberts JE & Tyler VE (1998). Tyler’s Herbs of Choice. The Therapeutic Use of Phytomedicinals The Haworth Press, Inc., New York.
25. Blumenthal M, Brusse WR, Goldberg A, Gruenwald J, Hall T, Riggins CW & Rister RS (1998). The Complete German Commission E Monographs. Therapeutic Guide to Herbal Medicines The American Botanical Council, Austin, TX, USA.
26. Bulletin of the World Health Organization (1993). Research guidelines for evaluating the safety and efficacy of herbal medicine. Geneva, 1-86.
27. Keller K (1996). Herbal medicinal products in Germany and Europe: experiences with national and European assessment. Drug Information Journal, 30: 933-948.
28. Zeisel SH (1999). Regulation of “nutraceuticals”. Science, 285: 1853-1855.
29. Petrovick PR, Marques LC & Paula IC (1999). New rules for phytopharmaceutical drug registration in Brazil. Journal of Ethnopharmacology, 66: 51-55.
30. Eskinazi D, Blumenthal M, Farnsworth N & Riggins CW (1999). Botanical Medicine: Efficacy, Quality Assurance, and Regulation Mary Ann Liebert, Inc. Publisher, New York.
31. Brautigam MRH, Blommaert FA, Verleye G, Castermans J, Steur ENHJ & Kleijnen J (1998). Treatment of age-related memory complaints with Ginkgo biloba extract: a randomized double blind placebo-controlled study. Phytomedicine, 5: 425-434.
32. Kanowski S, Herrmann WM, Stephan K, Wierich W & Hörr R (1997). Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia. Phytomedicine, 4: 3-13.
33. Kleijnen J (1992). Knipschild P Ginkgo biloba. Lancet, 340: 1136-1139.
34. Ernst E, Rand JI & Stevinson C (1998). Complementary therapies for depression – An overview. Archives of General Psychiatry, 55: 1026-1032.
35. Harrer G, Schimidt U, Kuhn U & Biller A (1999). Comparison of equivalent between the St. John’s wort extract LoHyp-57 and fluoxetine. Arzneimittel-Forschung/Drug Research, 49: 289-296.
36. Josey ES & Tackett RL (1999). St. John’s wort: a new alternative for depression? International Journal of Clinical Pharmacology and Therapeutics, 37: 111-119.
37. Laakmann G, Schüle C, Baghai T & Kieser M (1998). St. John’s wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy. Pharmacopsychiatry, 31: 54-59.
38. Linde K, Raminez G, Mulrow CD, Pauls A, Weidenhammer W & Melchart D (1996). St. John’s wort for depression – an overview and meta-analysis of randomized clinical trials. British Medical Journal, 313: 253-258.
39. Vitiello B (1999). Hypericum perforatum extracts as potential antidepressants. Journal of Pharmacy and Pharmacology, 51: 513-517.
40. Woelk H, Burkard G & Grünwald J (1994). Benefits and risks of the Hypericum extract LI 160: drug monitoring study with 3250 patients. Geriatric Psychiatry and Neurology, 7 (Suppl 1): S34-S38.
41. Armstrong NC & Ernst E (1999). The treatment of eczema with Chinese herbs: a systematic review of randomized clinical trials. British Journal of Clinical Pharmacology, 48: 262-264.
42. Bauer R & Tittel G (1996). Quality assessment of herbal preparations as a precondition of pharmacological and clinical studies. Phytomedicine, 2: 193-198.
43. Bell LP, Hectorne K, Reynolds H, Balm TK & Hunninghake DB (1989). Cholesterol-lowering effects of psyllium hydrophilic mucilloid. Adjunct therapy to a prudent diet for patients with mild to moderate hypercholesterolemia. Journal of the American Medical Association, 261: 3419-3423.
44. Bensoussan A, Talley NJ, Hing M, Menzies R, Guo A & Ngu M (1998). Treatment of irritable bowel syndrome with Chinese herbal medicine: a randomized controlled trial. Journal of the American Medical Association, 280: 1585-1589.
45. Borchers AT, Hackman RM, Keen CL, Stern JS & Gershwin ME (1997). Complementary medicine: A review of immunomodulatory effects of Chinese herbal medicines. American Journal of Clinical Nutrition, 66: 1303-1312.
46. Diehm C, Trampisch HJ, Lange S & Schmidt C (1996). Comparison of leg compression stocking and oral horse-chestnut seed extract therapy in patients with chronic venous insufficiency. Lancet, 347: 292-294.
47. Fairfield KM, Eisenberg DM, Davis RB, Libman H & Phillips RS (1998). Patterns of use, expenditures, and perceived efficacy of complementary and alternative therapies in HIV-infected patients. Archives of Internal Medicine, 158: 2257-2264.
48. Grasso M, Montesano A, Buonaguidi A, Castelli M, Lania C, Rigatti P, Rocco F, Cesana BM & Borghi C (1995). Comparative effects of alfuzosin versus Serenoa repens in the treatment of symptomatic benign prostatic hyperplasia. Archives of Experimental Urology, 48: 97-103.
49. Högel J & Gaus W (1995). Studies on the efficacy of unconventional therapies. Arzneimittel-Forschung/Drug Research, 45: 88-92.
50. Johnson ES, Kadam NP, Hylands DM & Hylands PJ (1985). Efficacy of feverfew as prophylactic treatment of migraine. British Medical Journal, 291: 569-573.